Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.32B | 37.58B | 35.44B | 32.77B | 16.81B | 13.59B |
Gross Profit | 5.50B | 4.83B | 5.24B | 4.62B | -3.00M | -2.98B |
EBITDA | 4.17B | 4.30B | 5.33B | 3.85B | 31.00M | -5.49B |
Net Income | 1.23B | 1.38B | 1.67B | 791.00M | -2.19B | -6.77B |
Balance Sheet | ||||||
Total Assets | 48.14B | 47.05B | 45.32B | 43.34B | 42.54B | 39.48B |
Cash, Cash Equivalents and Short-Term Investments | 8.84B | 8.49B | 8.27B | 8.30B | 7.60B | 5.38B |
Total Debt | 14.10B | 14.23B | 13.95B | 15.17B | 16.69B | 15.38B |
Total Liabilities | 37.60B | 35.46B | 35.61B | 34.86B | 38.05B | 38.10B |
Stockholders Equity | 10.49B | 11.54B | 9.66B | 8.40B | 4.45B | 1.35B |
Cash Flow | ||||||
Free Cash Flow | 512.00M | -6.00M | 659.00M | 2.66B | -700.00M | -3.58B |
Operating Cash Flow | 4.33B | 3.89B | 4.71B | 5.17B | 618.00M | -2.33B |
Investing Cash Flow | -2.81B | -2.33B | -2.94B | -3.44B | -3.02B | -2.34B |
Financing Cash Flow | -1.15B | -1.45B | -2.07B | -2.27B | 2.87B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €8.77B | 7.11 | 12.35% | 3.56% | 6.98% | -12.63% | |
61 Neutral | C$6.52B | 9.25 | 3.44% | 2.88% | 6.99% | -11.09% | |
€5.97B | 14.32 | 9.15% | ― | ― | ― | ||
€1.84B | 55.38 | 5.42% | 0.31% | ― | ― | ||
€3.56B | 15.45 | 12.50% | 2.79% | ― | ― | ||
€3.56B | 11.14 | 12.50% | 4.47% | ― | ― | ||
74 Outperform | €14.20B | 5.64 | 14.10% | 5.99% | -2.53% | -4.91% |